Research Article
Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients
Table 1
Baseline characteristics of 3TC-naΓ―ve and experienced groups.
| | 3TC naΓ―ve () | 3TC experienced () | |
| Mean Age | 46 | 45 | | Male, % of patients | 83% | 89% | | Mean HBV DNA level (IU/mL) | 5.8 Γ 107 | 7.6 Γ 107 | | Mean ALT level (IU/L) | 46 | 82 | | Mean CD4 count (cells/mm3) | 155 | 333 | | Mean HIV RNA level (Copies/mL) | 59,285 | 30,034 | | HBeAg positive, no. of pts (%) | 7 (58%) | 11 (69%) | | HCV infection | 1 | 0 | |
|
|